Transdermal absorption of L-dopa from a new system composed of two separate layers of L-dopa and hydrogel in rats

被引:10
作者
Iwase, H
Sudo, J [1 ]
Terui, J
Kakuno, K
Watanabe, T
Takayama, K
Nagai, T
机构
[1] Hlth Sci Univ Hokkaido, Fac Pharmaceut Sci, Dept Clin Pharmacol & Toxicol, Ishikari, Hokkaido 0610293, Japan
[2] Hoshi Univ, Dept Pharmaceut, Shinagawa Ku, Tokyo 1428501, Japan
关键词
L-dopa; hydrogel; rat; transdermal absorption;
D O I
10.1081/DDC-100101294
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
To maintain the stability of L-dopa in hydrogel, a new system composed of two separate layers of L-dopa and hydrogel was developed. L-Dopa sheets were made by immersing L-dopa solutio into wipe sheets and by lyophilizing them. Examination for stability of L-dopa in the L-dopa sheet revealed that its stability was maintained for at least 12 weeks, providing the sheet was kept at room temperature in a dark box. In a cutaneous adsorption study of L-dopa in rats, an L-dopa sheet was attached to the shaved abdominal skin. A hydrogel composed of cutaneous adsorption enhancers, water and ethanol, was spread on vinyl tape (hydrogel sheet), and this sheet was placed over the L-dopa sheet. L-Dopa that was administered transdermally effectively penetrated through the skin: The plasma level of L-dopa peaked at 30 min and remained high between 60 and 180 min after the cutaneous application. Our system, composed of two separated layers of L-dopa and hydrogel, enabled the stability of L-dopa to be maintained without losing transdermal absorption of L-dopa.
引用
收藏
页码:755 / 759
页数:5
相关论文
共 13 条
[1]   LIQUID-CHROMATOGRAPHIC ASSAY FOR PHENYLETHANOLAMINE N-METHYLTRANSFERASE [J].
BORCHARDT, RT ;
VINCEK, WC ;
GRUNEWALD, GL .
ANALYTICAL BIOCHEMISTRY, 1977, 82 (01) :149-157
[2]  
ELLENHORN MJ, 1988, MED TOXICOLOGY DIAGN, P16
[3]   DETERMINATION OF CATECHOLAMINES IN RAT-HEART TISSUE AND PLASMA SAMPLES BY LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION [J].
ERIKSSON, BM ;
PERSSON, BA .
JOURNAL OF CHROMATOGRAPHY, 1982, 228 (MAR) :143-154
[4]   Chronic levodopa therapy enhances dopa absorption: Contribution to wearing-off [J].
Murata, M ;
Mizusawa, H ;
Yamanouchi, H ;
Kanazawa, I .
JOURNAL OF NEURAL TRANSMISSION, 1996, 103 (10) :1177-1185
[5]  
OHARA N, 1994, INT J PHARM, V105, P31
[6]   STRUCTURE ACTIVITY RELATIONSHIP OF 1-ALKYLAZACYCLOALKANONE OR 1-ALKENYLAZACYCLOALKANONE DERIVATIVES AS PERCUTANEOUS PENETRATION ENHANCERS [J].
OKAMOTO, H ;
HASHIDA, M ;
SEZAKI, H .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (05) :418-424
[7]   ANTI-PARKINSONIAN DRUGS TODAY [J].
QUINN, NP .
DRUGS, 1984, 28 (03) :236-262
[8]   AROMATIC L-AMINO-ACID DECARBOXYLASE ACTIVITY IN CENTRAL AND PERIPHERAL-TISSUES AND SERUM OF RATS WITH L-DOPA AND L-5-HYDROXYTRYPTOPHAN AS SUBSTRATES [J].
RAHMAN, MK ;
NAGATSU, T ;
KATO, T .
BIOCHEMICAL PHARMACOLOGY, 1981, 30 (06) :645-649
[9]  
REIMHERR FW, 1980, AM J PSYCHIAT, V137, P73
[10]   ON-OFF RESPONSE - CLINICAL AND BIOCHEMICAL CORRELATIONS DURING ORAL AND INTRAVENOUS LEVODOPA ADMINISTRATION IN PARKINSONIAN PATIENTS [J].
SHOULSON, I ;
GLAUBIGER, GA ;
CHASE, TN .
NEUROLOGY, 1975, 25 (12) :1144-1148